Precipio, Inc.
(NASDAQ : PRPO)

( )
PRPO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.29%80.010.9%$589.41m
CELGCelgene Corporation
-1.22%137.171.1%$556.07m
AMGNAmgen Inc.
0.05%186.281.1%$452.39m
BIIBBiogen Inc.
0.03%344.581.2%$391.35m
REGNRegeneron Pharmaceuticals, Inc.
-0.72%439.372.7%$313.54m
ALNYAlnylam Pharmaceuticals, Inc
-0.97%117.5510.7%$253.20m
VRTXVertex Pharmaceuticals Incorporated
-0.12%154.861.9%$219.44m
INCYIncyte Corporation
-0.43%115.142.5%$206.28m
ALXNAlexion Pharmaceuticals, Inc.
-2.04%140.241.9%$178.91m
ILMNIllumina, Inc.
-0.42%205.623.5%$138.87m
EXELExelixis, Inc.
-2.72%27.536.5%$135.05m
BLUEBluebird Bio, Inc.
-0.79%139.1017.3%$114.78m
BMRNBioMarin Pharmaceutical Inc.
-5.26%88.624.4%$108.97m
CLVSClovis Oncology, Inc.
-3.20%78.7216.5%$108.85m
SRPTSarepta Therapeutics, Inc.
-0.58%51.4216.9%$107.58m

Company Profile

Precipio, Inc. engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. The firm intends to invest in further development of its ICP technology to define specific clinical applications, as well as simplifying the adaptability and implementation of ICP technology for its customers. Its products include technology suite, MX-ICP, ICEme kits, genetic assays, and platforms. The company is headquartered in Omaha, NE.